Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Apellis Pharmaceuticals (APLS) Tax Rate (2022 - 2025)

Historic Tax Rate for Apellis Pharmaceuticals (APLS) over the last 5 years, with Q3 2025 value amounting to 0.28%.

  • Apellis Pharmaceuticals' Tax Rate rose 13300.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.65%, marking a year-over-year increase of 46000.0%. This contributed to the annual value of 0.59% for FY2024, which is 1900.0% down from last year.
  • Per Apellis Pharmaceuticals' latest filing, its Tax Rate stood at 0.28% for Q3 2025, which was up 13300.0% from 1.2% recorded in Q2 2025.
  • Apellis Pharmaceuticals' Tax Rate's 5-year high stood at 0.88% during Q4 2022, with a 5-year trough of 1.63% in Q4 2023.
  • For the 5-year period, Apellis Pharmaceuticals' Tax Rate averaged around 0.41%, with its median value being 0.3% (2024).
  • As far as peak fluctuations go, Apellis Pharmaceuticals' Tax Rate crashed by -25100bps in 2023, and later surged by 13300bps in 2025.
  • Quarter analysis of 5 years shows Apellis Pharmaceuticals' Tax Rate stood at 0.24% in 2021, then skyrocketed by 468bps to 0.88% in 2022, then tumbled by -286bps to 1.63% in 2023, then skyrocketed by 56bps to 0.73% in 2024, then skyrocketed by 138bps to 0.28% in 2025.
  • Its Tax Rate was 0.28% in Q3 2025, compared to 1.2% in Q2 2025 and 0.37% in Q1 2025.